Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma

International Journal of Molecular Medicine

Volumn 3, Issue 4, 1999, Pages 373-379

  Fiel Gan, Mary D ^a   Almeida, Lisa M ^b   Rose, Donna C ^a   Takano, Angela ^a   Rezuke, William N ^a   Coleman, William B ^a   Garcia, Nicole F ^a   Tsongalis, Gregory J ^b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bcl gene; Hematology; Mantle cell lymphoma

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PRIMER DNA;

AGED; ARTICLE; CELL CYCLE; CELL DIVISION; CHROMOSOME 11; CHROMOSOME 14; DNA SEQUENCE; FEMALE; GENE TRANSLOCATION; GENETIC MARKER; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTOMA; MALE; METHODOLOGY; MUTATION; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; CELL CYCLE; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; DNA PRIMERS; FEMALE; GENES, P53; GENETIC MARKERS; HUMANS; KI-67 ANTIGEN; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 0033113885     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.4.373     Document Type: Article

References (30)

1. Chan JK, Banks PM, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Stein H and Warnke RA: A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group: a summary version. Am J Clin Pathol 103: 543-560, 1995.
2. Williams ME, Westermann CD and Swerdlow SH: Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 76: 1387-1391, 1990.
3. Rosenberg CL, Wong E, Petty EM, et al: PRAD-1, a candidate bcl-1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88: 9638-9642, 1991.
4. Seto M, Yamamoto K, Iida S, et al: Gene rearrangement and overexpression of PRAD-1 in lymphoid malignancy with t(11;14) (q13;q32) translocation. Oncogene 7: 1401-1406, 1992.
5. Motokura T, Bloom T, Kim HG, et al: A novel cyclin encoded by bcl1-linked candidate oncogene. Nature 350: 512-515, 1991.
6. Velders GA, Kluin-Nelemans JC, De Boer CJ, Hermans J, Noordijk EM, Schuuring E, Kramer MHH, van Deijk WA, Rahder JB, Kluin PM and van Kreiken JHJM: Mantle cell lymphoma: a population-based clinical study. J Clin Oncol 14: 1269-1274, 1996.
7. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP and Grogan TM: A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucossa-associated lymphoid tissue and monocytoid B-cell subcategories). Blood 85: 1075-1082, 1995.
8. Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A and Armitage JO: The role of high dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 6: 263-266, 1995.
9. Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS and Gribben JG: Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease. Blood 90: 4212-4221, 1997.
10. Vandenberghe E: Mantle cell lymphoma. Blood Rev 8: 79-87, 1994.
11. Ott G, Ott MM, Kalla J, Helbing A, Schryen B, Katzenberger T, Bartek J, Durr A, Muller JG, Kreipe H and Muller-Hermelink HK: Genetic lesions in mantle cell lymphoma. Recent Results Cancer Res 143: 307-319, 1997.
12. Ott MM, Ott G, Kuse R, Porowski P, Gunzer U, Feller AC and Muller-Hermelink HK: The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 24: 329-334, 1994.
13. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R: P53 mutations in human lymphoid malignancies: associated with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88: 5413-5417, 1991.
14. Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K and Saito H: Mutations of P53 gene and their relation to disease progression in B-cell lymphoma. Blood 79: 2701-2707, 1992.
15. Prokocimer M and Rotter V: Structure and function of P53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 84: 2391-2411, 1994.
16. Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VVVS, Schluger A and Chaganti RSK: p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 86: 2892-2899, 1995.
17. Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E and Raffeid M: p53 gene mutations and protein over-expression are associated with aggressive variants of mantle cell iymphomas. Blood 87: 3351-3359, 1996.
18. Fields S and Jang SK: Presence of a potent transcription activating sequence in the p53 protein. Science 249: 1046-1049, 1990.
19. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
20. Coleman WB and Tsongalis GJ: Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 41: 644-657, 1995.
21. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
22. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, Braylan RC and Kjeldsberg CR: Antigen expression and polymerase chain reaction amplification of mantle cell lymphoma. Blood 8: 1626-1631, 1994.
23. Lehman TA, Bennett WP, Metcalf RA, et al: p53 mutations, ras mutations, and p53 heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096, 1991.
24. Tsongalis GJ, Kaufmann WK, Wilson SJ, et al: Rapid screening for p53 mutations with a sensitive heteroduplex detection technique. Clin Chem 40: 485-486, 1994.
25. Segal GH, Masih AS, Canavan Fox A and Jorgensen T: CD5-expressing B cell non-Hodgkin's lymphomas with bcl-1 gene rearrangements have a relatively homogeneous immunophenotype and are associated with an overal prognosis. Blood 85: 1570-1579, 1995.
26. Pich A, Ponti R, Valente G, Chiusa L, Geuna M, Novero D and Palestro G: Mib-1, Ki-67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol 47: 18-22, 1994.
27. Kumar S, Krenacs L, Otsuki T, Kumar D, Harris CA, Wellmann A, Jaffe ES and Raffeld M: bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 105: 737-743, 1996.
28. Lim LC, Segal GH and Wittwer CT: Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin embedded tissues. Am J Clin Pathol 104: 689-695, 1995.
29. Luthra R, Hai S and Pugh WC: Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagn Mol Pathol 4: 4-7, 1995.
30. Williams ME, Swerdlow SH, Rosenberg CL and Arnold A: Characterization of chromosome 11 translocation breakpoints at the Bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 52:55415-55445, 1992.